Equitable Trust’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.36M Sell
68,588
-6,685
-9% -$523K 0.27% 73
2025
Q1
$5.46M Buy
75,273
+2,231
+3% +$162K 0.3% 65
2024
Q4
$5.41M Buy
73,042
+7,154
+11% +$530K 0.3% 69
2024
Q3
$4.35M Buy
65,888
+52,154
+380% +$3.44M 0.28% 79
2024
Q2
$1.27M Buy
13,734
+2,115
+18% +$195K 0.09% 161
2024
Q1
$1.11M Buy
11,619
+962
+9% +$91.9K 0.08% 183
2023
Q4
$813K Buy
10,657
+5,129
+93% +$391K 0.06% 209
2023
Q3
$383K Buy
5,528
+521
+10% +$36.1K 0.03% 300
2023
Q2
$472K Buy
5,007
+197
+4% +$18.6K 0.04% 269
2023
Q1
$398K Hold
4,810
0.03% 293
2022
Q4
$359K Buy
4,810
+1,308
+37% +$97.6K 0.03% 310
2022
Q3
$289K Hold
3,502
0.02% 316
2022
Q2
$333K Buy
3,502
+202
+6% +$19.2K 0.02% 314
2022
Q1
$388K Hold
3,300
0.02% 287
2021
Q4
$428K Buy
+3,300
New +$428K 0.03% 275
2021
Q3
Sell
-5,313
Closed -$550K 365
2021
Q2
$550K Sell
5,313
-4,883
-48% -$505K 0.04% 237
2021
Q1
$853K Hold
10,196
0.06% 185
2020
Q4
$930K Buy
10,196
+413
+4% +$37.7K 0.07% 185
2020
Q3
$781K Sell
9,783
-366
-4% -$29.2K 0.07% 186
2020
Q2
$702K Sell
10,149
-1,974
-16% -$137K 0.06% 187
2020
Q1
$762K Buy
12,123
+8,463
+231% +$532K 0.08% 171
2019
Q4
$285K Hold
3,660
0.03% 248
2019
Q3
$268K Hold
3,660
0.03% 250
2019
Q2
$225K Sell
3,660
-213
-5% -$13.1K 0.02% 263
2019
Q1
$247K Buy
+3,873
New +$247K 0.03% 252
2018
Q4
Sell
-3,660
Closed -$212K 273
2018
Q3
$212K Buy
+3,660
New +$212K 0.02% 280